The positive trends emerging from the use of AI tools in biology, in particular, biological design tools and large language models, reveal a potency that extends biotechnology’s classic dual-use concerns. In terms of basic issues of what can go wrong, translational risks can lead to incorrect findings from data. Yet there is also an existential risk represented by threats like nefarious actors mis
Christine Parthemore
CEO of the Janne E. Nolan Center on Strategic Weapons
In a June 2026 report she coauthored, Christine Parthemore wrote that AI tools used in biology can help people but could also be misused to make stronger bioweapons more accessible.
Coauthor of Biotech and Biosecurity Policymakers Must Elevate Their Focus on DataPublished June 2026 · date of remarks not establishedCouncil on Strategic Risks report
Context and checks
Surrounding words
… must address and urges the US government to move swiftly to implement policy drivers that enable the generation, storage, and strategic, careful dissemination of such data for national security. What Could Go Right – and Wrong? The positive trends emerging from the use of AI tools in biology, in particular, biological design tools and large language models, reveal a potency that extends biotechnology’s classic dual-use concerns. In terms of basic issues of what can go wrong, translational risks can lead to incorrect findings from data. Yet there is also an existential risk represented by threats like nefarious actors mis using these tools to create enhanced bioweapons, and increasing their accessibility and perceived utility to a wider range of actors.
What this quote does not say
- The report names Parthemore as one of three authors, so the passage is jointly attributable but cannot be assigned to her as its sole drafter.
How this was checked
- Quote matched character-for-character against the captured page.
Reviewed by
an AI reviewer that read the whole source · an automatic character-by-character check